Matt Dyer πŸ‡ΊπŸ‡¦

Getting stuff done

πŸ“ United StatesπŸ”„ Updated September 2026πŸ’Ό 1 investmentsπŸ“… 4 years investingπŸ—“ Last invested Jul 2022
VC🌍 United States
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
4y
Years active

Portfolio

0 investments Β· sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience Β· 2 entries
All (2)
Investments (1)
2022
Executive Advisor / Investor
Jul 2022
Foresite Capital is a multi-stage healthcare and life sciences investment firm with ~ $3.5B in assets under management (as of 06/30/24). The firm aims to address areas of great unmet need by funding promising healthcare and life sciences businesses at all stages of their life cycles. Foresite Capital uses a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare, including 10x Genomics, Relay Therapeutics, Element Biosciences, Inscripta, as well as companies developing next generation therapeutics. Founded in 2011, Foresite Capital is based in San Francisco.
2012
Associate Director / Group Leader, Informatics Applications
Dec 2012
Life Technologies is now part of Thermo Fisher Scientific. To see what’s new, go to https://www.linkedin.com/company/thermo-fisher-scientific Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $17 billion and approximately 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.